Event in Progress:
Discover the latest content that has just been published on Research Tree
Thales published 9M results in line with market expectations, having benefitted from the strong momentum in avionics, accompanied by a robust performance in D&S. DIS saw mixed figures, with a collapse in the payment and sim card businesses offset by a solid performance from the biometric and cybersecurity activities. Given the good performance in 9M, Thales has re-iterated its FY23 guidance.
Companies: Thales (HO:EPA)Thales SA (HO:PAR)
Thales has published H1 23 figures above our expectations. Order intake stood at €8.6bn (+5.2% vs AV) and sales at €8.7bn (+1.4% vs AV) while the underlying EBITA stood at €993m (+1.3% vs AV). However, after 5 exceptionally strong quarters, the DIS segment experienced a pricing headwind, which we believe will continue in H2.
The company has marginally upgraded its guidance to +5-7% yoy organically (prev:4-7%) but, considering the latest FX rate, the absolute figures lie slightly below our curre
Thales has entered into exclusive negotiations to acquire Cobham Aerospace Communications, a supplier of advanced safety cockpit communication systems, for $1.1bn (financed in cash). At 17x EV/EBIT multiple, the deal is expensive but, with the company’s unique offering, better margins and vertical integration, we believe that Thales has struck a great deal.
Thales published good Q1 sales figures of €4.03bn (+7.9% yoy and +2.5% vs consensus). Sales were largely driven by the civil side, in particular, civil aeronautics (ongoing traffic recovery) and biometrics. The orderbook grew by 14%, driven by the defense business. The company remains confident that it can achieve its full year target and hence has left its guidance unchanged at 4-7% organic growth with a 11.5-11.8% EBIT margin.
Thales published good FY22 figures with sales and EBITA both in line with the consensus and FCF beating the market expectations. However, the company has given dull guidance for FY23, with FCF even below the market consensus. This comes as a negative surprise given that the sector has entered a new super-cycle with the onset of the war and a sharp recovery in civil traffic.
Thales published a solid set of Q3 results. The strong momentum in order intake continued in Q3 and sales increased strongly thanks to outperformance from the DIS activity. The company increased its FY22 sales guidance and reiterated its EBIT margin outlook. Thales seems well positioned to show resilience, even in a recessionary environment.
Thales has published robust H1 results. The massive Rafales contract has been recorded and pushed the order intake to a new record, boosting FCF with the downpayments associated with it. The improved guidance is mainly due to FX, and the organic sales midpoint has only improved by 50bp, which is in line with our view. Thales is still committed to bolt-on acquisitions of less than €500m, but does not totally exclude Atos.
Thales Q1 figures came as no surprise to the market. Despite the contract wins in space, the commercial traction for the other business divisions has been slow. As it will take time for governments to organize and place orders for Thales solutions, the FY22 guidance remains unchanged, which is a slight disappointment. Although the mid-term fundamentals of Thales remain exceptionally strong, we believe most of the positive dynamic has been already been factored into the stock price.
Thales has reported strong Q4 results, with the order intake at its highest level and strong cash generation. It has resulted in the first share buy-back programme in Thales’ history. The given guidance was a disappointment but does not encompass the major momentum that Defence companies have been witnessing in the current days due to the intensifying Ukraine/Russia war. Though the short-term consequences will be shy on financial figures, the long-term growth of the stock is unquestionable.
Thales has provided solid numbers which were globally in line with consensus. It has confirmed its new guidance (without the Transport division), where it seems well on track to achieve it. Overall, we are still impatiently waiting for an M&A opportunity to see which sector Thales will reinforce.
In 2016, the French group DCNS (currently known as the Naval Group) had won the largest contract in the history of Australia with a value of AUD90bn worth of conventional submarines. After five years of escalating tensions between the Australian government and the Naval Group due to technical issues, the Australian government announced today that it would drop the Naval Group in favour of a new alliance with the US and the UK.
After months of rumours, Thales finally found an acquirer of its Ground Transportation System business: the Japanese company Hitachi. This transaction will be paid in cash and the business will be considered as a discontinued operation for FY21. Therefore, guidance has been re-adjusted.
Thales published a solid set of results for its H1 this morning. All key figures are above consensus: order intake, sales, EBIT and FCF. Its guidance has been improved and the range is now more precise.
The return to growth of Thales is warmly welcomed by investors. The order intake was higher than expectations and proves that a recovery is in place. FY21 is expected to be a great year for Thales, with all sectors improving with time.
Results came in line with expectations, with still good commercial momentum and a major positive surprise concerning cash generation. Guidance points towards a return to growth in 2021, matching expectations. Buy recommendation reiterated.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Thales.
We currently have 29 research reports from 2
Companies: eEnergy Group PLC
Companies: Clarkson PLC
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices.
As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP FTSV GSF SEIT USFP HICL ORIT BSIF TRIG NESF JLEN SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
eEnergy has announced (1st March) a new £40m project funding facility, which will support the Group’s public sector customers with their energy transition projects over coming years. It is an innovative arrangement, which will see eEnergy retain an interest in the economics of each completed project, enhancing margins and driving growth in Energy Services revenue.
A brief year-end trading update indicated that trading in the 6-months to Dec ‘23 was impacted by balance sheet constraints (prior t
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (
Companies: TXG NDVA TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL DEMG AGY TSTL IPO GDR ETX TRX HVO HVO CTEC AVO OXB DEST VLG IXI VAL ERGO INDV AGR AVCT BAI 123F IMCR BCOW
Companies: Luceco PLC
Somero’s FY23 trading update confirmed as in-line with expectations, with slightly better cash generation improving net cash to $33m. FY24 forecasts were introduced conservatively pitched with stable revenues, helped by new products and further opex investment in Australia and Europe, with a new facility opening in Belgium. We retain our TP at 585p, offering upside to current levels, even after the shares recent rally, and an attractive FY23 dividend yield of 6.8%.
Companies: Somero Enterprises, Inc.
Companies: AVG RBD NEXN
The group has seen a very strong H1 performance, with decent momentum in Chain markets but driven by the strong increase in output in Cardiff in the TT division. Margins in particular saw a strong improvement with both divisions generating ROS of 16%. Order intake has continued to see some softer conditions, with ordering patterns normalising, although this results in a lower order book, particularly in Europe. On strong H1 results management expect FY24 to be ahead of expectations. We upgrade F
Companies: Renold plc
The three key points in today’s update from discoverIE (for the first four months of H2) are that the growth in design wins (a measure of new business creation) has improved from +23% in H1 to +25% YTD, orders have returned to growth and the multiples paid for acquisitions are coming down. In January 2024, the group made a small, higher-margin bolt-on acquisition for the magnetics cluster in North America for a mid-single-digit EBIT multiple. Hence, metrics for long-term value creation on both a
Companies: discoverIE Group PLC
Companies: Yu Group PLC
In a Trading Update for the 3 months to 31 December 2023, Supreme reports “excellent trading performance” during its traditionally busiest quarter, leading to the expectation that FY24 revenue should be at least £225m with (adj.) EBITDA of at least £38m (our estimates were £221.2m and £33.5m). Supreme highlights in particular the success of ElfBar distribution revenue and the Vaping division as a whole, plus growth in Sports Nutrition & Wellness.
The Group also notes the UK Government decision
Companies: Supreme PLC
On 9 January last year, we set out our ten top stock picks for 2023, for what turned out to be another relatively poor twelve months for UK equities due to two wars, stubbornly high inflation and further tightening of monetary policy. This was even as other major markets, such as the US, largely recovered in the year. In the 2023 calendar year, the AIM All-Share index fell 8.2% and is still 42% off its 2021 high. From the release of our 2023 top picks note, the average total return (assuming div
Companies: PTAL GHH IGP MSLH PINE NXQ EQLS NXR AXL
Avingtrans reported FY24 interim results in-line with expectations with good growth and an improving operational performance. We maintain our existing forecasts. The formation of Advanced Engineering Systems (AES) by merging the PSRE and EPM divisions makes sense. Ongoing investment in Medical Imaging continues to make encouraging progress in its potentially market disrupting compact MRI and 3D X-Ray imaging equipment. The shares do not reflect the potential disposal valuations for the engineeri
Companies: Avingtrans plc